FDA Approves Endologix’s Bifurcated Endograft System

The FDA has granted a PMA supplement to Irvine, Calif-based Endologix for its AFX2 Bifurcated Endograft System for the treatment of abdominal aortic aneurysms.

The device reduces the steps for the delivery and deployment of the bifurcated endograft and facilitates percutaneous endovascular aneurysm repair by providing contralateral access.

Endologix is a developer and manufacturer of minimally invasive treatments for aortic disorders. — Michael Cipriano